• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺富含糖原透明细胞癌的临床及病理特征

Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast.

作者信息

Kuroda Hajime, Sakamoto Goi, Ohnisi Kiyoshi, Itoyama Shinji

机构信息

Saitama Medical Center, Saitama Medical School, 1981, Tsujido, Kamoda, Kawagoe, Saitama 350-8550, Japan.

出版信息

Breast Cancer. 2005;12(3):189-95. doi: 10.2325/jbcs.12.189.

DOI:10.2325/jbcs.12.189
PMID:16110288
Abstract

BACKGROUND

Twenty cases of invasive ductal carcinoma of the breast with a pure or partial glycogen-rich clear cell carcinoma(GRCC)component are reported. GRCC of the breast is composed almost entirely of polygonal cells with clear cytoplasm. These contain large amounts of partly water-soluble glycogen.

METHODS

The cases were analyzed using various parameters, including age at presentation, tumor size, tumor grade, axillary lymph node and Her2/neu status.

RESULTS

Between 1990 and 2004, 723 patients with primary breast carcinomas were treated and clinicopathologic analysis was performed. 20 cases were identified as GRCC among the 723 cases. The patients' age at presentation ranged from 33 to 68 years (mean, 52 years). Tumor size ranged from 1 to 6.5 cm (mean, 2.6 cm); 35% (7 of 20) of cases that underwent axillary dissection had positive lymph nodes. Among 15 of 20 cases who were followed for 1-72 months, 5 cases died from their breast carcinoma within 5 years following the diagnosis.

CONCLUSION

Our series included more small size carcinomas than did previous series. Lymph node status does not appear to be markedly different from that of the usual invasive ductal carcinomas. Her2/neu expression was similar to that found in common breast carcinomas.

摘要

背景

报告了20例乳腺浸润性导管癌,伴有纯或部分富含糖原的透明细胞癌(GRCC)成分。乳腺GRCC几乎完全由细胞质透明的多边形细胞组成。这些细胞含有大量部分水溶性糖原。

方法

使用各种参数对这些病例进行分析,包括就诊年龄、肿瘤大小、肿瘤分级、腋窝淋巴结和Her2/neu状态。

结果

1990年至2004年间,723例原发性乳腺癌患者接受了治疗并进行了临床病理分析。在723例病例中,有20例被鉴定为GRCC。患者就诊年龄范围为33至68岁(平均52岁)。肿瘤大小范围为1至6.5厘米(平均2.6厘米);接受腋窝清扫的病例中有35%(20例中的7例)淋巴结阳性。在20例中有15例随访了1至72个月,其中5例在诊断后5年内死于乳腺癌。

结论

我们的系列病例中,小尺寸癌比以前的系列更多。淋巴结状态似乎与普通浸润性导管癌没有明显差异。Her2/neu表达与常见乳腺癌中的表达相似。

相似文献

1
Clinical and pathological features of glycogen-rich clear cell carcinoma of the breast.乳腺富含糖原透明细胞癌的临床及病理特征
Breast Cancer. 2005;12(3):189-95. doi: 10.2325/jbcs.12.189.
2
Clinicopathologic characteristics and prognosis of glycogen-rich clear cell carcinoma of the breast.乳腺富含糖原的透明细胞癌的临床病理特征及预后
Breast J. 2014 Mar-Apr;20(2):166-73. doi: 10.1111/tbj.12231. Epub 2014 Jan 9.
3
Glycogen-rich clear cell carcinoma of the breast. A clinicopathologic study of 21 cases.乳腺富含糖原的透明细胞癌。21例临床病理研究。
Am J Surg Pathol. 1995 Aug;19(8):904-11. doi: 10.1097/00000478-199508000-00005.
4
Fine needle aspiration cytology of glycogen-rich clear cell carcinoma of the breast: review of 37 cases with histologic correlation.乳腺富含糖原透明细胞癌的细针穿刺细胞学检查:37例与组织学相关性的回顾
Acta Cytol. 2008 Jan-Feb;52(1):65-71. doi: 10.1159/000325436.
5
Can we identify the group of small invasive (T1a,b) breast cancers with minimal risk of axillary lymph node involvement? A pathohistological and DNA flow cytometric study.我们能否确定具有最小腋窝淋巴结受累风险的小浸润性(T1a,b)乳腺癌群体?一项组织病理学和 DNA 流式细胞术研究。
Pathol Res Pract. 2011 Jul 15;207(7):438-42. doi: 10.1016/j.prp.2011.04.005. Epub 2011 Jun 20.
6
Clear cell carcinoma of breast lipid-rich variant.乳腺富脂质型透明细胞癌
J Cancer Res Ther. 2019 Jul-Sep;15(5):1167-1169. doi: 10.4103/jcrt.JCRT_870_17.
7
[Expression of fatty acid synthase and its association with HER2 in invasive ductal carcinoma of breast].[脂肪酸合酶在乳腺浸润性导管癌中的表达及其与HER2的关系]
Zhonghua Bing Li Xue Za Zhi. 2013 Apr;42(4):257-61. doi: 10.3760/cma.j.issn.0529-5807.2013.04.010.
8
Glycogen-rich carcinomas of the breast display unique characteristics with respect to proliferation and the frequency of oligonucleosomal fragments.
Breast Cancer Res Treat. 1999 Sep;57(2):215-9. doi: 10.1023/a:1006285819701.
9
Clinical and pathologic features of invasive micropapillary carcinoma.浸润性微乳头癌的临床和病理特征
Breast Cancer. 2004;11(2):169-74. doi: 10.1007/BF02968297.
10
Clinicopathological significance of HER2/neu genetic heterogeneity in HER2/neu non-amplified invasive breast carcinomas and its concurrent axillary metastasis.HER2/neu 非扩增型浸润性乳腺癌及其腋窝转移中 HER2/neu 基因异质性的临床病理意义。
J Clin Pathol. 2013 Aug;66(8):649-54. doi: 10.1136/jclinpath-2012-201403. Epub 2013 Mar 28.

引用本文的文献

1
Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer.靶向糖原合酶 1 揭示了三阴性乳腺癌的代谢脆弱性。
J Exp Clin Cancer Res. 2023 Jun 6;42(1):143. doi: 10.1186/s13046-023-02715-z.
2
Excellent long term oncological outcome in a patient with rare glycogen rich clear cell carcinoma of breast following breast conservation surgery.保乳手术后,一名患有罕见的富含糖原透明细胞癌的乳腺癌患者获得了出色的长期肿瘤学预后。
Int J Surg Case Rep. 2022 Oct;99:107640. doi: 10.1016/j.ijscr.2022.107640. Epub 2022 Sep 15.
3
Triple-negative breast cancer: A run-through of features, classification and current therapies.
三阴性乳腺癌:特征、分类及当前治疗方法概述
Oncol Lett. 2021 Jul;22(1):512. doi: 10.3892/ol.2021.12773. Epub 2021 May 5.
4
Glycogen-rich clear cell carcinoma of the breast with solid papillary pattern: Two cases with heterogeneous clinicopathological features.具有实性乳头结构的乳腺富含糖原透明细胞癌:两例临床病理特征各异的病例
Exp Ther Med. 2021 May;21(5):524. doi: 10.3892/etm.2021.9956. Epub 2021 Mar 22.
5
Glycogen rich clear cell carcinoma of the breast: a rare subtype with good prognosis.
J Surg Case Rep. 2019 May 16;2019(5):rjz150. doi: 10.1093/jscr/rjz150. eCollection 2019 May.
6
Clinical Features, Survival and Prognostic Factors of Glycogen-Rich Clear Cell Carcinoma (GRCC) of the Breast in the U.S. Population.美国人群中乳腺富含糖原透明细胞癌(GRCC)的临床特征、生存情况及预后因素
J Clin Med. 2019 Feb 14;8(2):246. doi: 10.3390/jcm8020246.
7
Glycogen Rich Clear Cell Carcinoma (GRCC) of the breast may not have a poor prognosis.乳腺富含糖原的透明细胞癌(GRCC)预后可能并不差。
Int J Surg Case Rep. 2017;33:92-96. doi: 10.1016/j.ijscr.2017.02.044. Epub 2017 Feb 27.
8
Invasive ductal carcinoma of the breast with osteoclast-like giant cells and clear cell features: a case report of a novel finding and review of the literature.伴有破骨细胞样巨细胞和透明细胞特征的乳腺浸润性导管癌:一例新发现病例报告及文献复习
World J Surg Oncol. 2016 Aug 26;14(1):227. doi: 10.1186/s12957-016-0982-6.
9
Glycogen-rich clear cell carcinoma of the breast: a case report.乳腺富含糖原的透明细胞癌:一例报告
J Med Ultrason (2001). 2009 Mar;36(1):39-43. doi: 10.1007/s10396-008-0200-4. Epub 2009 Mar 14.
10
Clear Cell Carcinoma of the Breast: A Rare Breast Cancer Subtype - Case Report and Literature Review.乳腺透明细胞癌:一种罕见的乳腺癌亚型——病例报告与文献综述
Case Rep Oncol. 2015 Nov 4;8(3):472-7. doi: 10.1159/000441838. eCollection 2015 Sep-Dec.